BDBM3154 2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]bicyclo[2.2.1]heptan-2-yl}oxy)carbonyl]phenyl}carbonyl)-3-hydroxybenzoic acid::Balanol analog 20::Balanol analog 21

SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)OC1C2CCC(C2)C1NC(=O)c1ccc(O)cc1

InChI Key

Data  19 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 19 hits for monomerid = 3154   

TargetProtein kinase C delta type(Human)
Sphinx Laboratories

LigandPNGBDBM3154(2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 3.50E+3nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

LigandPNGBDBM3154(2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 1.90E+3nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

LigandPNGBDBM3154(2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 5.00E+4nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

LigandPNGBDBM3154(2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 1.90E+3nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

TargetProtein kinase C zeta type(Human)
Sphinx Laboratories

LigandPNGBDBM3154(2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 5.00E+4nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

TargetProtein kinase C zeta type(Human)
Sphinx Laboratories

LigandPNGBDBM3154(2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 3.70E+4nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

TargetProtein kinase C eta type(Human)
Sphinx Laboratories

LigandPNGBDBM3154(2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 4.50E+3nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

TargetProtein kinase C eta type(Human)
Sphinx Laboratories

LigandPNGBDBM3154(2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 20nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

TargetProtein kinase C epsilon type(Human)
Sphinx Laboratories

LigandPNGBDBM3154(2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 1.50E+3nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

TargetProtein kinase C epsilon type(Human)
Sphinx Laboratories

LigandPNGBDBM3154(2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 30nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

TargetProtein kinase C alpha type(Human)
Sphinx Laboratories

LigandPNGBDBM3154(2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 55nMpH: 7.5 T: 2°CAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

TargetProtein kinase C delta type(Human)
Sphinx Laboratories

LigandPNGBDBM3154(2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 20nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

TargetProtein kinase C gamma type(Human)
Sphinx Laboratories

LigandPNGBDBM3154(2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 1.00E+4nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

TargetProtein kinase C gamma type(Human)
Sphinx Laboratories

LigandPNGBDBM3154(2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 35nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3154(2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 6.90E+3nMpH: 7.5 T: 2°CAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3154(2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 30nMpH: 7.5 T: 2°CAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3154(2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 1.70E+4nMpH: 7.5 T: 2°CAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3154(2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 45nMpH: 7.5 T: 2°CAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

TargetProtein kinase C alpha type(Human)
Sphinx Laboratories

LigandPNGBDBM3154(2-({2,6-dihydroxy-4-[({3-[(4-hydroxybenzene)amido]...)
Affinity DataIC50: 2.40E+4nMpH: 7.5 T: 2°CAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article